mr-107a-02
Generic: fast-absorbing meloxicam·Code: MR-107A-02
mr-107a-02: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Viatris Inc (VTRS) | Phase 3 |
Clinical Trials (1)
Multi-Center, Randomized, Double-Blind, Placebo (Double-Dummy) and Active-Controlled, Parallel-Group Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
Frequently asked questions
Who is developing mr-107a-02?
mr-107a-02 is being developed by Viatris Inc.
How many clinical trials involve mr-107a-02?
BioSniper tracks 1 clinical trial involving mr-107a-02.
Get deeper analysis on mr-107a-02
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis